THE COMPARATIVE EFFECTIVENESS OF CYCLING TUMOURNECROSIS FACTOR INHIBITOR (TNFI) VERSUS SWAPPING TO A NONTNFI ON PATIENT-REPORTED FUNCTIONAL ABILITY OF PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Lopez-Oliva, M. A. [1 ]
Matusevich, A. [1 ]
Cantor, S. B. [2 ]
Pratt, G. [3 ]
Suarez-Almazor, M. E. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Gen Internal Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Hlth Serv Res, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Res Med Lib, Houston, TX 77030 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.6989
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0298
引用
收藏
页码：196 / 196
页数：1
相关论文
共 50 条
  • [21] FACTORS INFLUENCING SELECTION OF BIOLOGIC THERAPY AND COMPARATIVE EFFECTIVENESS IN PATIENT REPORTED OUTCOMES AMONG PATIENTS WITH RHEUMATOID ARTHRITIS
    Curtis, J. R.
    Navarro-Millan, I.
    Chen, L.
    Harrold, L. R.
    Liu, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 554 - 554
  • [22] Cycling Versus Swapping in Patients with Rheumatoid Arthritis with an Inadequate Response to at Least One Tumor Necrosis Factor Alpha Inhibitor: A Systematic Review and Meta-Analysis of Observational Studies
    Lopez-Olivo, Maria A.
    Matusevich, Aliza
    Suarez-Almazor, Maria
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [23] CYCLING VERSUS SWAPPING IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO AT LEAST ONE TUMOR NECROSIS FACTOR ALPHA INHIBITOR: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES
    Lopez-Olivo, M. A.
    Matusevich, A.
    Suarez-Almazor, M. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 851 - 851
  • [24] COMPARATIVE EFFECTIVENESS OF RITUXIMAB VERSUS ANTI-TUMOR NECROSIS FACTOR SWITCHING FOR RHEUMATOID ARTHRITIS PATIENTS
    Harrold, L.
    Reed, G.
    Magner, R.
    Shewade, A.
    John, A.
    Reiss, W.
    Greenberg, J.
    Kremer, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 460 - 460
  • [25] Comparative Effectiveness of Tocilizumab (TCZ) Monotherapy with Tumor Necrosis Factor Inhibitors (TNFi) in Combination with Varying Doses of Methotrexate (MTX) in Patients with Rheumatoid Arthritis
    Harrold, Leslie R.
    Reed, George W.
    Best, Jennie
    Zlotnick, Steve
    Persuitte, Gioia
    Kremer, Joel
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [26] COMPARATIVE EFFECTIVENESS OF TOCILIZUMAB (TCZ) MONOTHERAPY WITH TUMOR NECROSIS FACTOR INHIBITORS (TNFI) IN COMBINATION WITH VARYING DOSES OF METHOTREXATE (MTX) IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Harrold, L. R.
    Reed, G. W.
    Best, J.
    Zlotnick, S.
    Persuitte, G.
    Kremer, J. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1191 - 1192
  • [27] Comparative Effectiveness Of Rituximab Vs. Subsequent Anti-Tumor Necrosis Factor In Patients With Rheumatoid Arthritis With Prior Exposure To TNFi.
    Harrold, Leslie R.
    Reed, George W.
    Magner, Robert P.
    Shewade, Ashwini
    John, Ani
    Greenberg, Jeffrey D.
    Kremer, Joel M.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S610 - S610
  • [28] Systematic Review of Economic Evaluations of Cycling Versus Swapping Medications in Patients With Rheumatoid Arthritis After Failure to Respond to Tumor Necrosis Factor Inhibitors
    Karpes Matusevich, Aliza R.
    Suarez-Almazor, Maria E.
    Cantor, Scott B.
    Lal, Lincy S.
    Swint, J. Michael
    Lopez-Olivo, Maria A.
    ARTHRITIS CARE & RESEARCH, 2020, 72 (03) : 343 - 352
  • [29] COMPARATIVE DISEASE BURDEN IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS OR ANKYLOSING SPONDYLITIS: DATA FROM COVAD PATIENT-REPORTED E-SURVEY
    Venerito, V.
    Fornaro, M.
    Iannone, F.
    Cavagna, L.
    Kuwana, M.
    Agarwal, V.
    Ravichandran, N.
    Day, J.
    Joshi, M.
    Saha, S.
    Shaharir, S. S.
    Katchamart, W.
    Goo, P. A.
    Traboco, L.
    Chen, Y. M.
    Sen, P.
    Lilleker, J. B.
    Nune, A.
    Pauling, J.
    Wincup, C.
    Tan, A. L.
    Ziade, N.
    Milchert, M.
    Gracia-Ramos, A. E.
    Caballero, C. Vinicio
    Study, C.
    Agarwal, V.
    Aggarwal, R.
    Gupta, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 746 - 747
  • [30] Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis
    Strand, Vibeke
    Gossec, Laure
    Proudfoot, Clare W. J.
    Chen, Chieh-I
    Reaney, Matthew
    Guillonneau, Sophie
    Kimura, Toshio
    van Adelsberg, Janet
    Lin, Yong
    Mangan, Erin K.
    van Hoogstraten, Hubert
    Burmester, Gerd R.
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
12345